Drug intelligence / Profile preview

copper-64 chloride

Development stage
Unknown
Lead developer
Advanced Center Oncology Macerata
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

Copper-64 chloride is a radiopharmaceutical precursor used primarily for the radiolabelling of other molecules, enabling their use in positron emission tomography (PET) imaging. It contains the radioactive isotope copper‑64, which emits beta radiation and has a half-life of 12.7 hours. When used as a precursor, it is not administered directly to patients but is instead attached to carrier molecules that target specific tissues or cells in the body. The compound is distributed mainly to the liver and kidneys after administration, with rapid clearance from blood into these organs before redistribution throughout the body. Its primary clinical application is as a diagnostic agent for PET imaging in oncology and other fields where targeted molecular imaging is required[1][2][3][5][8].

Brand names
Cuprymina
Other names
copper (64Cu) chloridecupric chloride anhydrous Cu-64Copper Cu-64
02

Targets

SLC31A1 (Human copper transporter 1)

Beyond the preview

Go deeper on copper-64 chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on copper-64 chloride.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call